Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab
Clinical trial NCT03157830 · COMPLETED
Trial details
- NCT number
- NCT03157830
- Sponsor
- Providence Health & Services
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-06-01
- Primary completion
- 2022-01-28
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.